Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

CUSIP: G8807B106

Q3 2024 13F Holders as of 30 Sep 2024

Security identity
Security type / class
Equity / Ordinary Share $0.00001 Par Value
Shares outstanding
51,428,000
Holder snapshot
Total 13F shares
45,764,660
Share change
-1,432,457
Total reported value
$368,891,703
Put/Call ratio
6400%
Reported price per share
$8.06
Number of holders
118
Value change
-$13,728,533
Number of buys
50
Number of sells
65

Security key

G8807B106

Report period

Q3 2024

Institutions

118

Top holders

10

TBPH full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2024 Previous quarter: Q2 2024 Theravance Biopharma, Inc. SEC filings Theravance Biopharma, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Madison Avenue Partners, LP
13D/G signal
—
Evidence rows
15
Latest as of
30 Jun 2024
13F 3/4/5 Lead comparable stake: 17% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Madison Avenue Partners, LP
13F
Company
13F
17%
$72,176,248
8,511,350 shares
 — 30 Jun 2024
Weiss Asset Management LP
3/4/5 13F
10%+ Owner · Company
3/4/5 13F
14%
from 13F
$76,733,147
7,457,060 shares
 — 19 Sep 2022
BAUPOST GROUP LLC/MA
13F
Company
13F
8.2%
$35,616,000
4,200,021 shares
 — 30 Jun 2024
BlackRock Finance, Inc.
13F
Company
13F
7.4%
$32,055,756
3,780,160 shares
 — 30 Jun 2024
Irenic Capital Management LP
13F
Company
13F
5.4%
$23,412,839
2,760,948 shares
 — 30 Jun 2024
Newtyn Management, LLC
13F
Company
13F
4.1%
$18,017,481
2,124,703 shares
 — 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
118
Shares
45,764,660
Rows available
118
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
129
Q3 2024 holders
118
Holder diff
-11
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .